ReviewMedical oncology (Northwood, London, England)2026
Risk-adapted first-line therapy selection in advanced EGFR-mutant NSCLC: a practical clinical algorithm integrating tumor biology and patient factors.
Ashish Sharma et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.